Study of Oral Weekly Lepetegravir (Formerly GS-1720) and Lenacapavir Pacfosacil (Formerly GS-4182) Versus Biktarvy in People With HIV-1 Who Are Virologically Suppressed
Clinical trial NCT06544733 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06544733
- Sponsor
- Gilead Sciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-20
- Primary completion
- 2028-01-01
- Enrollment
- 675
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.